Replies to post #692914 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Correct call from 2014.

>>The DCVax PIM designation will prove to be as meaningless as the German "hospital exemption" announced in March.

Correct:

>>The buyers of Northwest's convertible notes want the company's stock price to decline before Feb. 15, 2015, because a lower stock price will also drop the conversion price of the debt when it resets. A lower conversion price means note holders get more and cheaper Northwest shares to sell when they convert the notes. The Northwest debt holders also make extra money by shorting the stock and covering lower.

>>And Northwest will be happy to make its convertible notes more profitable for current holders at the expense of equity shareholders because when the company needs to raise cash again next year (and Northwest will definitely raise more money next year) it will find a receptive audience. Vulture investors love distressed companies who make it easy to book profits.

https://www.thestreet.com/investing/northwest-bios-almost-toxic-debt-raise-responsible-for-stock-slide-12885672